State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.
State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
J Control Release. 2020 Mar 10;319:25-45. doi: 10.1016/j.jconrel.2019.12.028. Epub 2019 Dec 17.
Tumor hypoxia is a characteristic hallmark of malignant solid tumors, which remains an essential impediment to many current treatments like chemotherapy, radiotherapy, photodynamic therapy and immunotherapy, thereby leading to poor clinical prognosis after therapy. Rationally, modulating tumor hypoxia can be of great interest to augment the therapeutic efficacy of these treatments. In this review, we focus our discussion on current advances in nanoparticles-mediated tumor reoxygenation strategy for relieving tumor hypoxia to improve the therapeutic efficacy of versatile therapies. These nanoparticles can improve tumor oxygen levels via nanoparticles-mediated oxygen-carrying or oxygen-generating tactics to synergize the effectiveness of many current therapeutic modalities. Based on these considerable summaries and analyses, we propose some feasible perspectives on nanoparticles-based tumor reoxygenations to ameliorate the therapeutic outcomes.
肿瘤缺氧是恶性实体瘤的一个特征性标志,这仍然是许多当前治疗方法(如化疗、放疗、光动力疗法和免疫疗法)的一个重要障碍,从而导致治疗后的临床预后不佳。合理地说,调节肿瘤缺氧对于提高这些治疗方法的疗效具有重要意义。在这篇综述中,我们集中讨论了纳米颗粒介导的肿瘤再氧合策略在缓解肿瘤缺氧以提高多种治疗方法疗效方面的最新进展。这些纳米颗粒可以通过纳米颗粒介导的载氧或产氧策略来提高肿瘤的氧水平,从而协同多种当前治疗方式的有效性。基于这些相当全面的总结和分析,我们提出了一些基于纳米颗粒的肿瘤再氧合的可行观点,以改善治疗效果。